Nirogacestat demonstrates clinically significant improvement in PFS versus placebo for progressing desmoid tumours
Nirogacestat demonstrates clinically significant improvement in PFS versus placebo for progressing desmoid tumours
Treatment with tumour-infiltrating lymphocytes versus ipilimumab significantly improved PFS for advanced melanoma
Cervical cancer programme in Kenya: lessons to guide elimination as a public health problem
An overview of treatment advances in gastric cancer
Optimum treatment strategy algorithm for mCRC
Bladder cancer: Current state and future directions in treatment
Optimum treatment algorithm in management of advanced prostate cancer
Working to improve global cancer care access in low middle-income countries
Update on the latest in PARP inhibitors for prostate cancer
ASCO Direct Highlights 2022: prostate cancer highlights
ASCO Direct Highlights 2022: lung cancer highlights
Locally and advanced immunotherapy developments and new agents in lung cancer